REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Surya Dermato Medica Laboratories (Indonesia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: PT Surya Dermato Medica Laboratories Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Surya Dermato Medica Laboratories is an enterprise in Indonesia, with the main office in Surabaya. The company operates in the Medicinal and Botanical Manufacturing industry. The enterprise was incorporated on May 17, 1968. It currently has a total number of 101 - 500 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 3.33% in 2023. A growth of 4.04% was recorded in its total assets.

Headquarters
Surabaya Industrial Estate Rungkut (SIER)
Surabaya; East Java; Postal Code: 60293

Contact Details: Purchase the PT Surya Dermato Medica Laboratories report to view the information.

Website: http://www.sdm-labs.com

Basic Information
Total Employees:
Purchase the PT Surya Dermato Medica Laboratories report to view the information.
Outstanding Shares:
Purchase the PT Surya Dermato Medica Laboratories report to view the information.
Registered Capital:
Purchase the PT Surya Dermato Medica Laboratories report to view the information.
Incorporation Date:
May 17, 1968
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Surya Dermato Medica Laboratories report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
3.33%
Total operating revenue
3.33%
Total assets
4.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?